论文信息 - Key populations for early COVID-19 immunization: preliminary guidance for policy

Key populations for early COVID-19 immunization: preliminary guidance for policy

KEY POINTS Alarming levels of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggered the World Health Organization (WHO) to declare novel coronavirus disease 2019 (COVID-19) a pandemic on Mar. 11, 2020.[1][1] The pandemic is ongoing and has caused substantial morbidity and

M. Tunis | S. Deeks | C. Quach | S. Ismail | Linlu Zhao

[1] M. Tunis,et al. Navigating inequities: a roadmap out of the pandemic , 2020, BMJ Global Health.

[2] A. Gates,et al. A systematic review of factors that influence the acceptability of vaccines among Canadians. , 2020, Vaccine.

[3] M. Tunis,et al. Ranking the relative importance of COVID-19 immunisation strategies: a survey of expert stakeholders in Canada , 2020, medRxiv.

[4] M. Gates,et al. Risk factors for severe outcomes of COVID-19: a rapid review , 2020, medRxiv.

[5] F. Hou,et al. Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study , 2020, BMJ.

[6] Kelsey Young,et al. A framework for the systematic consideration of ethics, equity, feasibility, and acceptability in vaccine program recommendations , 2020, Vaccine.

[7] S. Luo,et al. Association of Personal Protective Equipment Use with Successful Protection Against COVID-19 Infection Among Health Care Workers , 2020, medRxiv.

[8] È. Dubé,et al. Determinants of non-vaccination against seasonal influenza. , 2018, Health reports.

[9] Holger J Schünemann,et al. Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines. , 2015, Annals of internal medicine.

[10] J. Langley,et al. Canada's National Advisory Committee on Immunization (NACI): evidence-based decision-making on vaccines and immunization. , 2010, Vaccine.